Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Liver Diseases

Free Subscription 13.11.2023 4 Am J Gastroenterol 1 Am J Pathol 4 Biochem Biophys Res Commun 4 BMC Cancer 1 BMC Gastroenterol 1 Br J Surg 1 Cancer 3 Clin Res Hepatol Gastroenterol 2 Dig Dis Sci 5 Hepatology 2 Indian J Gastroenterol 1 J Clin Oncol 1 J Gastroenterol 1 J Hepatol 1 J Pediatr 2 J Pediatr Surg 2 Lancet 2 Oncogene 2 PLoS One 1 Radiol Imaging Cancer 4 Radiology 1 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. WANG B, Zhou J, Wu X, Sun Y, et al
   Carvedilol plus NUCs for compensated HBV-cirrhosis patients under virological suppression: a randomised, open-label trial.
   Am J Gastroenterol. 2023 Nov 6. doi: 10.14309/ajg.0000000000002569.
   PubMed         Abstract available
   
   
2. KULKARNI AV, Avadhanam M, Karandikar P, Rakam K, et al
   Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: A double-blind, randomized controlled (ARiE) trial.
   Am J Gastroenterol. 2023 Nov 9. doi: 10.14309/ajg.0000000000002575.
   PubMed         Abstract available
   
   
3. BAJAJ JS, Kamath PS, Reddy KR, Asrani SK, et al
   Predictors of Respiratory Failure Development in A Multi-Center Cohort of Inpatients with Cirrhosis.
   Am J Gastroenterol. 2023 Nov 8. doi: 10.14309/ajg.0000000000002574.
   PubMed         Abstract available
   
   
4. PATEL A, Bowman CA, Prause N, Kilaru SM, et al
   Outcomes of a Three-Year Quality Improvement Study to Improve Advance Care Planning in Patients with Decompensated Cirrhosis.
   Am J Gastroenterol. 2023 Nov 7. doi: 10.14309/ajg.0000000000002570.
   PubMed         Abstract available
   
   

   
   Am J Pathol

5. WARNER JB, Hardesty JE, Song YL, Floyd AT, et al
   Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.
   Am J Pathol. 2023 Nov 2:S0002-9440(23)00410-8. doi: 10.1016/j.ajpath.2023.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

6. JIN Q, Hu Y, Gao Y, Zheng J, et al
   Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish.
   Biochem Biophys Res Commun. 2023;686:149182.
   PubMed         Abstract available
   
   
7. JUNG M, Ji E, Kang H, Kim C, et al
   The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
   Biochem Biophys Res Commun. 2023;686:149183.
   PubMed         Abstract available
   
   
8. HE J, Han J, Lin K, Wang J, et al
   PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.
   Biochem Biophys Res Commun. 2023;683:149117.
   PubMed         Abstract available
   
   
9. QU D, Chen M, Zhu H, Liu X, et al
   Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
   Biochem Biophys Res Commun. 2023;684:149131.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. ZHANG L, Su K, Liu Q, Li B, et al
    Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
    BMC Cancer. 2023;23:1081.
    PubMed         Abstract available
    
    
11. KLEMM S, Evert K, Utpatel K, Muggli A, et al
    Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis.
    BMC Cancer. 2023;23:1086.
    PubMed         Abstract available
    
    
12. WANG J, Peng Y, Jing S, Han L, et al
    A deep-learning approach for segmentation of liver tumors in magnetic resonance imaging using UNet+.
    BMC Cancer. 2023;23:1060.
    PubMed         Abstract available
    
    
13. NAKHARUTAI N, Chitapanarux I, Traisathit P, Srikummoon P, et al
    Prediction of survival and analysis of prognostic factors for hepatocellular carcinoma: a 20-year of imaging diagnosis in Upper Northern Thailand.
    BMC Cancer. 2023;23:1063.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

14. LI S, Feng L, Ding J, Zhou W, et al
    Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
    BMC Gastroenterol. 2023;23:376.
    PubMed         Abstract available
    
    

    
    Br J Surg

15. 
    Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

16. 
    Erratum to "Association between posttreatment alpha-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinoma".
    Cancer. 2023 Nov 4. doi: 10.1002/cncr.35102.
    PubMed        
    
    

    
    Clin Res Hepatol Gastroenterol

17. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed         Abstract available
    
    
18. ALLAIRE M, Roux C, Akhavan S, Lebray P, et al
    Difficulties in assessing portal hypertension in case of HVB-HVD co infection.
    Clin Res Hepatol Gastroenterol. 2023;47:102213.
    PubMed        
    
    
19. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

20. JAMES M, Alazawi W
    Non-invasive Tests of Fibrosis: Does One Size Fit All?
    Dig Dis Sci. 2023;68:4285-4286.
    PubMed        
    
    
21. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
    Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
    Dig Dis Sci. 2023;68:4485-4498.
    PubMed         Abstract available
    
    

    
    Hepatology

22. BRENNER DA
    Alternatives to animal testing to assess NASH drugs and hepatotoxicity.
    Hepatology. 2023 Nov 6. doi: 10.1097/HEP.0000000000000669.
    PubMed         Abstract available
    
    
23. SELLERS ZM, Assis DN, Paranjape SM, Sathe M, et al
    Cystic fibrosis screening, evaluation and management of hepatobiliary disease consensus recommendations.
    Hepatology. 2023 Oct 26. doi: 10.1097/HEP.0000000000000646.
    PubMed         Abstract available
    
    
24. QASIM KHAN M, Hassan S, Lizaola-Mayo BC, Bhat M, et al
    Navigating the 'Specific Etiology' steatohepatitis category: Evaluation & management of non-alcohol/non-metabolic dysfunction-associated steatohepatitis.
    Hepatology. 2023 Nov 7. doi: 10.1097/HEP.0000000000000674.
    PubMed        
    
    
25. LIU N, Tian J, Steer CJ, Han Q, et al
    MicroRNA-206-3p suppresses hepatic lipogenesis and cholesterol synthesis while driving cholesterol efflux.
    Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000672.
    PubMed         Abstract available
    
    
26. KARVELLAS CJ, Bajaj JS, Kamath PS, Napolitano L, et al
    AASLD Practice guidance on Acute-on-chronic liver failure and the management of critically Ill patients with cirrhosis.
    Hepatology. 2023 Nov 9. doi: 10.1097/HEP.0000000000000671.
    PubMed        
    
    

    
    Indian J Gastroenterol

27. GIRI S, Anand AC
    Non-cirrhotic intrahepatic portal hypertension: Is the gun loaded?
    Indian J Gastroenterol. 2023 Nov 9. doi: 10.1007/s12664-023-01466.
    PubMed        
    
    
28. JAIN AK, Bundiwal AK, Jain S, Agrawal P, et al
    Evaluation of liver and splenic stiffness by acoustic radiation force impulse for assessment of esophageal varices.
    Indian J Gastroenterol. 2023 Nov 6. doi: 10.1007/s12664-023-01456.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

29. WANG G, Zhuo N, Liu Z
    Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers.
    J Clin Oncol. 2023;41:5070.
    PubMed        
    
    

    
    J Gastroenterol

30. YANG Z, Shi M, Liang Y, Zhang F, et al
    Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus.
    J Gastroenterol. 2023 Nov 5. doi: 10.1007/s00535-023-02053.
    PubMed         Abstract available
    
    

    
    J Hepatol

31. LIU J, Qian J, Yang Z, Zhou L, et al
    Patients with Hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation:A meta-analysis.
    J Hepatol. 2023 Nov 6:S0168-8278(23)05231-5. doi: 10.1016/j.jhep.2023.
    PubMed        
    
    

    
    J Pediatr

32. GUPTA PM, Madewell ZJ, Gannon BM, Grahn M, et al
    Hepatic Vitamin A Concentrations and Association with Infectious Causes of Child Death.
    J Pediatr. 2023 Nov 4:113816. doi: 10.1016/j.jpeds.2023.113816.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

33. BAUZON J, Froehlich M, Dadon N, Morris D, et al
    Outcomes of Primary Tumor Excision do not Differ from Non-Resection Methods in Pediatric Mesenchymal Hamartoma of the Liver: A Rapid Systematic Review.
    J Pediatr Surg. 2023;58:2356-2361.
    PubMed         Abstract available
    
    
34. YOSRA K, Ghada H, Bochra A, Fatma T, et al
    Predictive Factors of Liver Hydatid Cyst Recurrence in Children.
    J Pediatr Surg. 2023;58:2362-2367.
    PubMed         Abstract available
    
    

    
    Lancet

35. VON KODOLITSCH Y, Kubisch C, Carrel T
    AATD as a genetic risk factor for aneurysmal disease - Authors' reply.
    Lancet. 2023;402:1626.
    PubMed        
    
    
36. KUEPPERS F
    AATD as a genetic risk factor for aneurysmal disease.
    Lancet. 2023;402:1625-1626.
    PubMed        
    
    

    
    Oncogene

37. ZHOU J, Xu W, Wu Y, Wang M, et al
    GPR37 promotes colorectal cancer liver metastases by enhancing the glycolysis and histone lactylation via Hippo pathway.
    Oncogene. 2023 Sep 25. doi: 10.1038/s41388-023-02841.
    PubMed         Abstract available
    
    
38. LIU F, Liao Z, Zhang Z
    MYC in liver cancer: mechanisms and targeted therapy opportunities.
    Oncogene. 2023;42:3303-3318.
    PubMed         Abstract available
    
    

    
    PLoS One

39. YANG H, Meng L, Xin S, Chang C, et al
    Non-linear association between aspartate aminotransferase to alanine aminotransferase ratio and mortality in critically ill older patients: A retrospective cohort study.
    PLoS One. 2023;18:e0293749.
    PubMed         Abstract available
    
    
40. MOON JJ, Hong SK, Kim YC, Hong SY, et al
    Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes.
    PLoS One. 2023;18:e0293844.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

41. LIN YM
    Noninferiority in Overall Survival with Thermal Ablation for Treating Small Colorectal Liver Metastases.
    Radiol Imaging Cancer. 2023;5:e239020.
    PubMed        
    
    

    
    Radiology

42. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    PubMed         Abstract available
    
    
43. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    PubMed         Abstract available
    
    
44. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.
    PubMed        
    
    
45. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

46. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.